Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison
DW Scheifele, SA McNeil, BJ Ward… - Human vaccines & …, 2013 - Taylor & Francis
To determine if newer influenza vaccines can safely improve seroprotection rates of older
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison.
DW Scheifele, SA McNeil, BJ Ward… - Human Vaccines & …, 2013 - europepmc.org
To determine if newer influenza vaccines can safely improve seroprotection rates of older
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison
DW Scheifele, SA Mcneil, BJ Ward… - HUMAN VACCINES …, 2013 - usiena-air.unisi.it
To determine if newer influenza vaccines can safely improve seroprotection rates of older
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison
DW Scheifele, SA McNeil, BJ Ward, M Dionne… - 2013 - open.library.ubc.ca
To determine if newer influenza vaccines can safely improve seroprotection rates of older
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison
DW Scheifele, SA McNeil, BJ Ward, M Dionne… - 2013 - pubmed.ncbi.nlm.nih.gov
To determine if newer influenza vaccines can safely improve seroprotection rates of older
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …
[HTML][HTML] Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: Results of a randomized, controlled comparison
DW Scheifele, SA McNeil, BJ Ward… - Human Vaccines & …, 2013 - ncbi.nlm.nih.gov
To determine if newer influenza vaccines can safely improve seroprotection rates of older
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison
DW Scheifele, SA McNeil, BJ Ward, M Dionne… - 2013 - open.library.ubc.ca
To determine if newer influenza vaccines can safely improve seroprotection rates of older
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison.
DW Scheifele, SA McNeil, BJ Ward… - Human Vaccines & …, 2013 - europepmc.org
To determine if newer influenza vaccines can safely improve seroprotection rates of older
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …